A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation

Clinical trial NCT07625215 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07625215
Sponsor: Bayer
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2026-08-31
Primary completion: 2030-05-16
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.